Ascomp With Codeine Capsule
NDC Package 51991-074-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Ascomp With Codeine (butalbital, aspirin, caffeine and codeine phosphate) capsules is see also Warning section. This formulation utilizes a capsule delivery system. Marketed by Breckenridge Pharmaceutical, Inc., this product is identified by NDC 51991-074 and is authorized under FDA application ANDA075231.

Identification & Billing

NDC Package Code
51991-074-01
Package Description
100 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
51991-074
11-Digit Billing Format
51991007401
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 994237 - butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
  • RxCUI: 994237 - aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
  • RxCUI: 994237 - ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
  • RxCUI: 994239 - Ascomp with Codeine 50 MG / 325 MG / 40 MG / 30 MG Oral Capsule
  • RxCUI: 994239 - aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp]

Clinical Specifications

Proprietary Name
Ascomp With Codeine
Non-Proprietary Name
Butalbital, Aspirin, Caffeine And Codeine Phosphate
Substance Name
Aspirin; Butalbital; Caffeine; Codeine Phosphate
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
See also Warning section. This combination medication is used to treat tension headaches. Codeine is an opioid pain reliever that acts on certain centers in the brain to give you pain relief. Aspirin helps to decrease the pain from the headache. Caffeine helps increase the effects of aspirin. Butalbital is a sedative that helps to decrease anxiety and cause sleepiness and relaxation.
DEA Schedule
Schedule III (CIII) Substances

Regulatory & Marketing

Labeler Name
Breckenridge Pharmaceutical, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA075231
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-01-2009
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51991-074). Click a package code to view its specific billing and regulatory data.

51991-074-05
500 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51991-074-01 identifies a specific commercial package of 100 capsule in 1 bottle, plastic of Ascomp With Codeine, a human prescription drug labeled by Breckenridge Pharmaceutical, Inc.. This capsule is formulated for oral use and contains aspirin; butalbital; caffeine; codeine phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Breckenridge Pharmaceutical, Inc. on May 01, 2009. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

See also Warning section. This combination medication is used to treat tension headaches. Codeine is an opioid pain reliever that acts on certain centers in the brain to give you pain relief. Aspirin helps to decrease the pain from the headache. Caffeine helps increase the effects of aspirin. Butalbital is a sedative that helps to decrease anxiety and cause sleepiness and relaxation.

How is this Breckenridge Pharmaceutical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51991007401. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51991-074-01
11-Digit CMS (5-4-2)
51991-0074-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.